Unlocking the potential of patient-centric continuous innovation: case studies for value added medicines

Now or never: Europe must seize the Pharma Legislation… 7 November 2023 Medicines for Europe, representing the European value-added medicines industry, is…
A streamlined, digital regulatory framework is the… 27 September 2023 The off-patent medicines sector accounts for almost 70% of medicines…
One- Pager: New pricing models for generic medicines 10 October 2022 How can we ensure a sustainable healthcare system while safeguarding…
(Original in SK) How low pricing of generic and biosimilar… 27 November 2023 the continuous increase in the prices of input raw materials…

WEBINAR